Your English writing platform
Discover LudwigSuggestions(2)
Exact(60)
Chemical optimization of this class of therapeutics may lead to an improved therapeutic window.
Monoclonal antibodies (mAbs) and antibody fragments have become an emerging class of therapeutics since 1986.
Histone deacetylase (HDAC) inhibitors are an important new class of therapeutics for treating multiple myeloma.
Monoclonal antibodies are among the most rapidly expanding class of therapeutics for cancer treatment.
But if Nanospectra can meet these challenges, it could usher in a fundamentally new class of therapeutics and help bring nanotechnology into the doctor's office.
Future directions for research and other applications for this novel class of therapeutics agents are considered in this chapter.
Over the past 15 years, monoclonal antibodies (mAbs) have emerged as the most successful class of therapeutics.
Antimicrobial peptides have emerged as a promising class of therapeutics for various systemic and topical clinical applications.
Monoclonal antibodies are a remarkably successful class of therapeutics used to treat a wide range of indications.
Monoclonal antibody pharmaceuticals are the fastest-growing class of therapeutics, with a wide range of clinical applications.
However, editing naturally occurring peptide sequences to develop peptidomimetic analogs created a promising class of therapeutics that can augment or inhibit molecular interactions.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com